Akt1, EMSY, BRCA2 and type I IFN signaling: A novel arm of the IFN response

Por Ezell, Scott A., Tsichlis, Philip N.
Publicado em 2012

The protein kinase Akt1 regulates the interferon response through phosphorylation of the transcriptional repressor EMSY

Por Ezell, Scott A., Polytarchou, Christos, Hatziapostolou, Maria, Guo, Ailan, Sanidas, Ioannis, Bihani, Teeru, Comb, Michael J., Sourvinos, George, Tsichlis, Philip N.
Publicado em 2012

The Downregulation of GFI1 by the EZH2-NDY1/KDM2B-JARID2 Axis and by Human Cytomegalovirus (HCMV) Associated Factors Allows the Activation of the HCMV Major IE Promoter and the Tra...

Por Sourvinos, George, Morou, Antigoni, Sanidas, Ioannis, Codruta, Ignea, Ezell, Scott A., Doxaki, Christina, Kampranis, Sotirios C., Kottakis, Filippos, Tsichlis, Philip N.
Publicado em 2014

Differential regulation of mTOR signaling determines sensitivity to AKT inhibition in diffuse large B cell lymphoma

Por Ezell, Scott A., Wang, Suping, Bihani, Teeru, Lai, Zhongwu, Grosskurth, Shaun E., Tepsuporn, Suprawee, Davies, Barry R., Huszar, Dennis, Byth, Kate F.
Publicado no Oncotarget (2016)

Phosphoproteomics screen reveals Akt isoform-specific signals linking RNA processing to lung cancer

Por Sanidas, Ioannis, Polytarchou, Christos, Hatziapostolou, Maria, Ezell, Scott A., Kottakis, Filippos, Hu, Lan, Guo, Ailan, Xie, Jianxin, Comb, Michael J., Iliopoulos, Dimitrios, Tsichlis, Philip N.
Publicado em 2014

Synergistic induction of apoptosis by combination of BTK and dual mTORC1/2 inhibitors in diffuse large B cell lymphoma

Por Ezell, Scott A., Mayo, Michele, Bihani, Teeru, Tepsuporn, Suprawee, Wang, Suping, Passino, Melissa, Grosskurth, Shaun E., Collins, Mike, Parmentier, Julie, Reimer, Corinne, Byth, Kate F.
Publicado em 2014

Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers

Por Bihani, Teeru, Ezell, Scott A., Ladd, Brendon, Grosskurth, Shaun E., Mazzola, Anne Marie, Pietras, Mark, Reimer, Corinne, Zinda, Michael, Fawell, Stephen, D'Cruz, Celina M.
Publicado no Oncotarget (2014)

NDY1/KDM2B functions as a master regulator of Polycomb complexes and controls self-renewal of breast cancer stem cells

Por Kottakis, Filippos, Foltopoulou, Parthena, Sanidas, Ioannis, Keller, Patricia, Wronski, Ania, Dake, Benjamin T., Ezell, Scott A, Shen, Zhu, Naber, Stephen P., Hinds, Philip W., McNiel, Elizabeth, Kuperwasser, Charlotte, Tsichlis, Philip N.
Publicado no Cancer Res (2014)

The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma

Por Kuo, Hsu-Ping, Ezell, Scott A, Hsieh, Sidney, Schweighofer, Karl J, Cheung, Leo WK, Wu, Shiquan, Apatira, Mutiah, Sirisawad, Mint, Eckert, Karl, Liang, Yu, Hsu, Jeff, Chen, Chun-Te, Beaupre, Darrin, Chang, Betty Y
Publicado no Am J Cancer Res (2016)

Correction to Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor

Por Kim, Hyung-Gu, Tan, Li, Weisberg, Ellen L., Liu, Feiyang, Canning, Peter, Choi, Hwan-Geun, Ezell, Scott, Zhao, Zheng, Wu, Hong, Wang, Jinhua, Mandinova, Anna, Bullock, Alex N., Liu, Qingsong, Lee, Sam W., Gray, Nathanael S.
Publicado em 2014

Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor

Por Kim, Hyung-Gu, Tan, Li, Weisberg, Ellen L., Liu, Feiyang, Canning, Peter, Choi, Hwan Geun, Ezell, Scott A., Wu, Hong, Zhao, Zheng, Wang, Jinhua, Mandinova, Anna, Griffin, James D., Bullock, Alex N., Liu, Qingsong, Lee, Sam W., Gray, Nathanael S.
Publicado em 2013